share_log

Talaris Therapeutics Q3 EPS $(0.46) Down From $(0.32) YoY

Benzinga Real-time News ·  Nov 10, 2022 07:10

Talaris Therapeutics (NASDAQ:TALS) reported quarterly losses of $(0.46) per share. This is a 43.75 percent decrease over losses of $(0.32) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment